Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Andreas P. Wagner Sells 7,632 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas P. Wagner sold 7,632 shares of the company’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $16.40, for a total value of $125,164.80. Following the completion of the sale, the insider now directly owns 223,474 shares of the company’s stock, valued at $3,664,973.60. The trade was a 3.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Alignment Healthcare Trading Up 2.7 %

Shares of NASDAQ ALHC opened at $17.19 on Thursday. The stock’s 50 day moving average price is $14.68 and its two-hundred day moving average price is $12.59. Alignment Healthcare, Inc. has a 52-week low of $4.46 and a 52-week high of $17.38. The stock has a market capitalization of $3.30 billion, a P/E ratio of -22.32 and a beta of 1.49. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Stephens reaffirmed an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a research report on Monday, February 24th. Piper Sandler upped their target price on Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 4th. JPMorgan Chase & Co. increased their price target on Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a report on Thursday, March 6th. Stifel Nicolaus increased their price target on Alignment Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a report on Friday, February 28th. Finally, Barclays increased their price target on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $14.83.

Institutional Trading of Alignment Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Alignment Healthcare by 3.9% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 56,963 shares of the company’s stock valued at $641,000 after buying an additional 2,154 shares in the last quarter. Rhumbline Advisers raised its position in shares of Alignment Healthcare by 2.2% during the 4th quarter. Rhumbline Advisers now owns 135,704 shares of the company’s stock worth $1,527,000 after purchasing an additional 2,937 shares during the period. MetLife Investment Management LLC raised its position in shares of Alignment Healthcare by 5.6% during the 4th quarter. MetLife Investment Management LLC now owns 61,344 shares of the company’s stock worth $690,000 after purchasing an additional 3,256 shares during the period. Alliancebernstein L.P. raised its position in shares of Alignment Healthcare by 2.8% during the 4th quarter. Alliancebernstein L.P. now owns 119,440 shares of the company’s stock worth $1,344,000 after purchasing an additional 3,300 shares during the period. Finally, Adage Capital Partners GP L.L.C. raised its position in shares of Alignment Healthcare by 15.0% during the 4th quarter. Adage Capital Partners GP L.L.C. now owns 34,497 shares of the company’s stock worth $388,000 after purchasing an additional 4,497 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.